Nova Biosource Fuels (NBFA) 8-K Entry into a Material Definitive Agreement

EXHIBIT 99.4

PRO FORMA CONDENSED FINANCIAL STATEMENTS

The following pro forma financial statements have been derived from the financial statements of Biosource America, Inc. (“Biosource America) at January 31, 2006 and adjusts such information to give effect to its asset purchase agreement of BIOsource Fuels, LLC as if the acquisition had occurred as of the end of the most recent interim period, January 31, 2006. The pro forma financial statements are presented for information purposes only and do not purport to be indicative of the financial condition that would have resulted if the acquisition had been consummated. The pro forma financial statements should be read in conjunction with the notes thereto and each Company’s consolidated financial statements and related notes thereto contained herein.

F-1

Biosource America, Inc.

Pro-Forma Balance Sheet

January 31, 2006

	BIOsource Fuels, LLC January 31, 2006					Biosource America, Inc. January 31, 2006					Pro Forma Adjustments						Pro-Forma Biosource America, Inc. January 31, 2006
ASSETS
Current assets
Cash	$			1,408,754		$			296,020	(2)	$				(408,754	)	$				1,296,020
Prepaid expenses	10,569					50,000				(2)	(10,569					)	50,000
Total current assets	1,419,323					346,020					(419,323					)	1,346,020
Property and equipment, net	344,512									(1)	680,488						1,025,000
Intangible assets	33,260									(1)	5,319,512						5,352,772
Total Assets	$			1,797,095		$			346,020		$			5,580,677			$			7,723,792
LIABILITIES AND OWNERS’ EQUITY (DEFICIT)
Current liabilities
Accounts payable & accrued expenses	$		190,694			$		11,498		(2)	$		(190,694			)	$		11,498
Due related parties	155,160					20,124				(2)	(155,160					)	20,124
Deferred revenues	1,243,181																1,243,181
Total current liabilities	1,589,035					31,622					(345,854					)	1,274,803
Long term debt
Notes payable to related parties	687,000									(2)	(687,000					)
Convertible debt										(1)	6,000,000						6,000,000
Total Liabilities	2,276,035					31,622					4,967,146						7,274,803
Owners equity (deficit)
Common Stock						350,000											350,000
Additional paid-in capital										(2)	134,591						134,591
Development stage deficit						(35,602				)							(35,602					)
Members’ contributions	591,682					0				(2)	(591,682					)	0
Accumulated deficit	(1,070,622				)	0				(2)	1,070,622						0
Total Owners’ Equity (Deficit)	(478,940				)	314,398					613,531						448,989
Total Liabilities & Owners’ Equity (Deficit)	$	1,797,095				$	346,020				$	5,580,677					$	7,723,792

(1) To record asset purchase agreement between BIOsource Fuels, LLC (seller) and Biosource America, Inc. (Buyer)

(2) To remove assets and liabilities of BIOsource Fuels not acquired in asset purchase agreement

F-2

Biosource America, Inc.

Pro-Forma Statement of Operations

For the Three Month Period Ended January 31, 2006 for BIOsource Fuels, LLC and

For the Period from Inception (December 1, 2005) to January 31, 2006 for Biosource America, Inc.

	BIOsource Fuels, LLC Three Months Ended January 31, 2006			Biosource America, Inc. Inception (December 1, 2005) to January 31, 2005			Pro Forma Adjustments			Pro-Forma Biosource America, Inc. Inception (December 1, 2005) to January 31, 2005
Revenues	$	799,819								$	799,819
Cost of revenue	751,575									751,575
Gross margin	48,244									48,244
Expenses
Selling, general andadministrative	100,746			$	35,602					136,348
Interest expense	18,586									18,586
Depreciation	21,402					(1)	$	8,334		29,736
Total operating expenses	140,734			35,602			8,334			184,670
Net Loss	$	(92,490	)	$	(35,602	)	$	(8,334	)	$	(136,426	)
Weighted average of shares/units outstanding	4,651			60,000,000			6,000,000			60,000,000

(1) To record additional depreciation on increased value assigned to fixed assets

F-3

	BIOsource Fuels, LLC Year Ended October 31, 2005			Biosource America, Inc. Inception(December 1, 2005) to January 31, 2005			Pro Forma Adjustments			Pro-Forma Biosource America, Inc. Annual Basis
Revenues	$	160,460								$	160,460
Expenses
Selling, general and administrative	382,215			$	35,602					417,817
Interest expense	59,088									59,088
Depreciation	77,434					(1)	$	33,334		110,768
Total operating expenses	518,737			35,602			33,334			587,673
Net Loss	$	(358,277	)	$	(35,602	)	$	(33,334	)	$	(427,213	)
Loss per unit	$	(77	)	$	(0	)	$	(0	)	$	(0	)
Weighted average of shares/units outstanding	4,651			60,000,000			6,000,000			60,000,000

F-4

These pro-forma financial statements have been presented to reflect the impact of the Asset Purchase Agreement entered into between Biosource America, Inc. (the buyer, “Biosource America”) and BIOsource Fuels, LLC (the seller, “BIOsource Fuels”). In connection with the Asset Purchase Agreement Biosource America agreed to purchase all of the equipment, leases, intellectual property, patents and patent applications, software, books and records of BIOsource Fuels and the cash, prepaid expenses and contract rights and liabilities associated with BIOsource Fuels contracting operations. Specifically excluded assets include cash, accounts receivable and prepaid expenses not related to the contracting business. The purchase price for the acquired assets is $6,000,000 allocated based upon the fair market value of assets acquired as detailed below:

Description	Amount
Property & equipment including pilot plant	$	1,025,000
Intangible assets including intellectual property including trade secrets, proprietary manufacturing information and know how, patents and patent applications, books and records	5,319,512
Total purchase price	$	6,000,000

The pro forma adjustments included in the pro forma financial statements included herein reflect the above asset allocation and any profit and loss effect for the related periods presented which include an increase to deprecation expense for the value assigned to depreciable assets.

F-5